Enter your credentials to acces your account.
PT-141, also known as bremelanotide, is a synthetic research peptide studied for its activity on melanocortin receptors in the central nervous system. In the UK, PT-141 is referenced exclusively for scientific research and educational purposes. It is not approved by the MHRA for human use.
Pure Peptides UK provides accurate, research-based information on PT-141 to support laboratory studies, academic discussion, and peptide education.
PT-141 is a laboratory-developed peptide derived from early melanocortin compounds. It was initially studied for effects on melanocortin receptor activity, which is involved in central nervous system signalling.
In academic research, PT-141 is often referenced for:
MC3R and MC4R receptor activation
Central nervous system neurotransmitter pathways
Peptide selectivity and receptor specificity
Pure Peptides UK provides this information in a strictly research-focused framework, aligned with UK regulatory guidance.
PT-141 is studied for its ability to selectively activate melanocortin receptors in the brain. These receptors are involved in:
Central signalling and neurotransmitter regulation
Neuroendocrine communication
Behavioural and physiological research pathways
Unlike other compounds, PT-141’s mechanism is centrally mediated, acting in the brain rather than through vascular or peripheral systems.
Pure Peptides UK presents this mechanism for educational clarity, without implying human use.
PT-141 is frequently referenced in peer-reviewed scientific journals for its unique receptor selectivity. Researchers study how the peptide influences neuroendocrine pathways and contributes to receptor-mediated effects in controlled laboratory settings.
Studies show PT-141 may affect neurotransmitter release in specific hypothalamic regions, providing a model for understanding central signalling without cardiovascular involvement.
PT-141 is a valuable tool in neuroendocrine research, helping scientists explore pituitary-brain interactions. By activating melanocortin receptors, PT-141 allows researchers to examine the downstream effects of central peptide signalling on other hormone-regulating systems.
Research on PT-141 often targets MC3R and MC4R receptors, which are integral to energy homeostasis and behavioural pathways. Understanding receptor specificity provides insights for broader neuroendocrine research, including potential therapeutic peptide development.
PT-141’s ability to cross the blood–brain barrier makes it an important reference compound for CNS peptide studies. Laboratory studies examine its impact on neuronal signalling, receptor modulation, and synaptic activity, offering a basis for advanced peptide research.
The selectivity of PT-141 for specific melanocortin receptors allows researchers to model peptide-receptor interactions accurately. By limiting off-target activity, PT-141 helps explore central peptide mechanisms in precise experimental conditions.
Laboratory studies of PT-141 often include pharmacokinetic models to evaluate absorption, distribution, metabolism, and excretion in non-human systems. These studies are critical for understanding peptide stability and receptor activity under controlled conditions.
PT-141 is often compared with other melanocortin receptor peptides in research to study differences in receptor affinity, signalling efficiency, and central nervous system effects. Such comparisons help define PT-141’s unique role in peptide science.
PT-141 provides a rich educational platform for students and researchers studying peptide chemistry, neuropharmacology, and receptor signalling. Its well-characterised receptor interactions make it ideal for teaching laboratories and demonstration studies.
PT-141 is legal for research purposes only in the UK and is not approved by the MHRA for human use. Educational and research guidance is critical for compliance with UK regulations, and Pure Peptides UK ensures all content aligns with legal requirements.
Pure Peptides UK offers trusted educational content and verified information on PT-141. By providing accurate scientific resources, the company supports research laboratories, universities, and academic institutions in peptide studies.
What is PT-141?
A synthetic peptide studied for melanocortin receptor activation and neuroendocrine pathways.
Is PT-141 legal in the UK?
Yes, for research purposes only. Not approved by the MHRA for human use.
What is PT-141 studied for?
Central nervous system signalling, melanocortin receptor selectivity, and neuroendocrine mechanisms.
Can PT-141 be used outside research?
No. It is strictly a research peptide.
Why reference PT-141?
To study receptor-specific signalling and central peptide mechanisms in laboratory settings.
This content is provided for scientific and educational information only. It summarises areas of ongoing research and does not constitute medical advice, product claims, or recommendations for human use.
Pure Peptides UK provides educational resources for research purposes only, with no endorsement for human application.
